Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Filgrastim
Related studies linked through entity extraction aliases.
Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE3
Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim
- Status
- COMPLETED
- Phase
- PHASE3
HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial
- Status
- TERMINATED
- Phase
- PHASE3
A Study of LY2523355 in Participants With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Scleroderma Treatment With Autologous Transplant (STAT) Study
- Status
- COMPLETED
- Phase
- PHASE2
Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- NA
Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
- Status
- UNKNOWN
- Phase
- N/A
Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Gene Therapy for Fanconi Anemia
- Status
- TERMINATED
- Phase
- PHASE1
Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Filgrastim With or Without Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide
- Status
- TERMINATED
- Phase
- PHASE3
Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological Patients
- Status
- TERMINATED
- Phase
- PHASE4